X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs PIRAMAL ENTERPRISES - Comparison Results

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE PIRAMAL ENTERPRISES TTK HEALTHCARE/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 33.9 39.0 86.9% View Chart
P/BV x 6.2 3.2 192.5% View Chart
Dividend Yield % 0.5 0.7 62.0%  

Financials

 TTK HEALTHCARE   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
PIRAMAL ENTERPRISES
Mar-17
TTK HEALTHCARE/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6632,095 31.7%   
Low Rs3991,025 38.9%   
Sales per share (Unadj.) Rs535.6492.8 108.7%  
Earnings per share (Unadj.) Rs15.972.6 22.0%  
Cash flow per share (Unadj.) Rs20.094.7 21.2%  
Dividends per share (Unadj.) Rs4.0021.00 19.0%  
Dividend yield (eoy) %0.81.3 55.9%  
Book value per share (Unadj.) Rs137.6862.5 16.0%  
Shares outstanding (eoy) m7.77172.56 4.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.03.2 31.3%   
Avg P/E ratio x33.321.5 154.9%  
P/CF ratio (eoy) x26.516.5 161.0%  
Price / Book Value ratio x3.91.8 213.4%  
Dividend payout %25.128.9 86.7%   
Avg Mkt Cap Rs m4,127269,194 1.5%   
No. of employees `0001.74.0 42.6%   
Total wages/salary Rs m60717,939 3.4%   
Avg. sales/employee Rs Th2,436.721,190.3 11.5%   
Avg. wages/employee Rs Th355.24,470.1 7.9%   
Avg. net profit/employee Rs Th72.53,120.0 2.3%   
INCOME DATA
Net Sales Rs m4,16285,037 4.9%  
Other income Rs m612,338 2.6%   
Total revenues Rs m4,22387,374 4.8%   
Gross profit Rs m19734,991 0.6%  
Depreciation Rs m323,817 0.8%   
Interest Rs m3020,310 0.1%   
Profit before tax Rs m19713,202 1.5%   
Minority Interest Rs m01,699 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-100 0.0%   
Tax Rs m732,281 3.2%   
Profit after tax Rs m12412,520 1.0%  
Gross profit margin %4.741.1 11.5%  
Effective tax rate %37.017.3 214.2%   
Net profit margin %3.014.7 20.2%  
BALANCE SHEET DATA
Current assets Rs m1,62987,590 1.9%   
Current liabilities Rs m1,058185,578 0.6%   
Net working cap to sales %13.7-115.2 -11.9%  
Current ratio x1.50.5 326.2%  
Inventory Days Days3031 95.9%  
Debtors Days Days3448 70.6%  
Net fixed assets Rs m556108,523 0.5%   
Share capital Rs m78345 22.5%   
"Free" reserves Rs m878148,481 0.6%   
Net worth Rs m1,069148,826 0.7%   
Long term debt Rs m159144,957 0.1%   
Total assets Rs m2,399482,394 0.5%  
Interest coverage x7.61.7 459.3%   
Debt to equity ratio x0.11.0 15.2%  
Sales to assets ratio x1.70.2 984.0%   
Return on assets %6.46.8 94.2%  
Return on equity %11.68.4 137.7%  
Return on capital %18.512.0 154.4%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3315,001 0.2%   
Fx outflow Rs m635,150 1.2%   
Net fx Rs m-309,851 -0.3%   
CASH FLOW
From Operations Rs m127-100,393 -0.1%  
From Investments Rs m-146-24,202 0.6%  
From Financial Activity Rs m22135,705 0.0%  
Net Cashflow Rs m311,110 0.0%  

Share Holding

Indian Promoters % 65.4 52.9 123.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 4.0 92.5%  
FIIs % 5.2 26.6 19.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 16.5 156.4%  
Shareholders   12,723 93,274 13.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   STRIDES SHASUN LTD  AJANTA PHARMA  SUVEN LIFE  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades on a Volatile Note; Airtel, Idea Down by 5%(01:30 pm)

After opening the day in green share markets in India witnessed choppy trading activity and are presently trading above the dotted line.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 24, 2018 01:53 PM

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE 8-QTR ANALYSIS

COMPARE TTK HEALTHCARE WITH

MARKET STATS